CClinicalTrials.gg
CompletedNCT01341366Updated Apr 30, 2013

Fast-track Perioperative Program for Laparoscopic Colorectal Surgery

A Phase 3 interventional study of Fast-track perioperative program and Traditional perioperative program in Colorectal Cancer, sponsored by Chinese University of Hong Kong. Completed at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2013-04-30.

Sponsored by Chinese University of Hong Kong · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Background:

Laparoscopic colorectal surgery has been shown by randomized trials to be associated with better short-term clinical outcomes when compared with open surgery. However, in a traditional perioperative care setting, the reduction in hospital stay following laparoscopic surgery in these trials was modest. Fast-track perioperative programs have been introduced in the West to optimize perioperative factors to reduce the physiological/psychological stress of open colorectal surgery. However, few studies have evaluated the impact of fast-track programs on the outcomes after laparoscopic colorectal surgery.

Objective:

To compare the clinical and immunological outcomes of Hong Kong Chinese patients undergoing laparoscopic surgery for colorectal cancer with a "traditional" vs. a "fast-track" perioperative program.

Design:

Prospective randomized trial.

Subjects:

One hundred and twenty-eight consecutive patients undergoing elective laparoscopic resection of non-metastatic colonic and upper rectal cancer will be recruited.

Interventions:

Patients will be randomized to a "traditional" or a "fast-track" perioperative program.

Outcome measures:

Primary outcome: total postoperative hospital stay, including hospital stay of patients who are readmitted within 30 days after surgery. Secondary outcomes: immunological parameters (including systemic cytokine response and cell-mediated immune function), morbidity and mortality, quality of life, and medical costs.

02

Conditions studied

  • Colorectal Cancer

Keywords

  • Laparoscopic surgery
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 128 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,419 studies on the registry; 487 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Consecutive patients undergoing elective laparoscopic resection of colonic and upper rectal cancer,
  • Age of patients between 18 and 75 years
  • Patients with American Society of Anesthesiologists grading I-II
  • Patients with no severe physical disability
  • Patients who require no assistance with the activities of daily living
  • Informed consent available

Exclusion criteria

Exclusion criteria:

  • Patients undergoing laparoscopic low anterior resection with total mesorectal excision, abdominoperineal resection, or total/proctocolectomy
  • Patients with planned stoma creation
  • Patients undergoing emergency surgery
  • Patients with known metastatic disease
  • Patients with previous history of abdominal surgery
  • Patients with known immunological dysfunction
  • Patients who are taking steroids or immunosuppressive agents
  • Patients with chronic pain syndrome
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
128 participants (actual)

Study arms

  • Experimental
    Fast-track perioperative program

    Other: Fast-track perioperative program

  • Active comparator
    Traditional perioperative program

    Other: Traditional perioperative program

Interventions

  • OtherFast-track perioperative program

    Preoperative counseling, no preoperative fasting, short-acting anesthetics, continuous infiltration of wound with local anesthetic agent, non-opioid pain management, the use of chewing gum, and early postoperative feeding and mobilization

  • OtherTraditional perioperative program

    Preoperative fasting, standard anesthetic management with no intraoperative fluid restriction, opioid pain management, no chewing gum, feeding/mobilization according to attending surgeon

06

What researchers measure

Primary outcomes

  1. Duration of hospital stay

    Total postoperative hospital stay, including hospital stay of patients who are readmitted within 30 days after surgery.

    Time frame: Up to 1 month

Secondary outcomes

  1. Pain scores

    Pain scores on visual analogue scale (from 0 which implies no pain at all, to 100 which implies the worst pain imaginable)

    Time frame: Up to 1 week

  2. Morbidity and mortality

    Time frame: Up to 1 month

  3. Readmission rate

    Time frame: Up to 1 month

  4. Quality of life

    Measured by SF-36, EORTC QLQ-C30 and QLQ-CR38 questionnaires

    Time frame: Up to 1 month

  5. Direct/indirect medical costs and out-of-hospital economic costs

    Time frame: Up to 1 month

  6. Systemic cytokine responses

    Blood levels of IL-1β, IL-6, and C-reactive protein

    Time frame: Up to 1 week

  7. Lymphocyte subsets

    Using flow cytometer to determine lymphocyte subsets and NK cell counts (cells/uL)

    Time frame: Up to 1 week

07

Study locations

1 site
  • Prince of Wales Hospital, The Chinese University of Hong Kong
    Hong Kong, China
08

References and documents

Related links

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01341366
Lead sponsor
Chinese University of Hong Kong
Responsible party
Simon S. M. Ng (Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Apr 25, 2011
Start date
Nov 2010
Primary completion
Mar 2013
Completion
Mar 2013
Last update
Apr 30, 2013

Study contacts

Simon SM Ng, MD
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion